Understanding Cockayne Syndrome Type 2: Genetic Testing as a Beacon of Hope
Explore how genetic testing helps diagnose and manage Cockayne Syndrome Type 2, a rare neurodegenerative disorder, by identifying specific DNA repair gene mutations.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Cracking the Code: Genetic Testing for Congenital Aniridia
Unlock personalized treatment for congenital aniridia. Genetic testing aids early diagnosis, family planning, and tailored care, improving vision and quality of life.
Comprehending Congenital Dyserythropoietic Anemia: The Role of Genetic Testing
Uncover how genetic testing enhances congenital dyserythropoietic anemia diagnosis, enabling personalized treatments and informed family planning strategies.
Congenital Long QT Syndrome: The Role of Genetic Testing in Understanding This Heart Disorder
Explore how genetic testing aids in diagnosing Long QT Syndrome, offering insights for at-risk individuals, personalized treatments, and informed family planning.
Cracking the Code: Understanding Congenital Membranous Nephropathy Due to Maternal Anti-Neutral Endopeptidase Alloimmunization
Explore congenital membranous nephropathy, a kidney disorder in newborns, and how genetic testing aids in early diagnosis, treatment, and family planning.
Congenital Myasthenic Syndrome: Unlocking Mysteries with Genetic Testing
Explore how genetic testing revolutionizes congenital myasthenic syndrome diagnosis, offering precision, tailored treatments, and informed family planning insights.
Cracking the Code: Genetic Testing for Congenital Nonbullous Ichthyosiform Erythroderma
Unlock better diagnosis and treatment for Congenital Nonbullous Ichthyosiform Erythroderma through genetic testing. Explore personalized care and family planning options.
Charting the Course: Genetic Testing in Congenital Omphalocele
Explore how genetic testing aids in diagnosing congenital omphalocele, identifies genetic syndromes, and guides family planning for improved outcomes.